Open Now
Contact Information
1419 Kensington Square Court, Murfreesboro, Tennessee 37130, United States
Detailed Information
Mental Health Cooperative Inc Cooperative Recovery
-
Services:
- Trauma-related counseling
- Telemedicine/telehealth therapy
- Brief intervention
- Motivational interviewing
- Substance use disorder counseling
- Cognitive behavioral therapy
- Relapse prevention
- Adults
- Seniors
- Mental health services
- Case management service
- Suicide prevention services
- Screening for substance use
- Comprehensive mental health assessment
- Professional interventionist/educational consultant
- Complete medical history/physical exam
- Interim services for clients
- Comprehensive substance use assessment
- Outreach to persons in the community
- Screening for tobacco use
- Screening for mental disorders
- Treatment for other addiction disorder
- Treatment for gambling disorder
- Naloxone and overdose education
- Outcome follow-up after discharge
- Sign language services for the deaf and hard of hearing
- Buprenorphine maintenance
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes naltrexone
- Prescribes buprenorphine
- Relapse prevention with naltrexone
- Male
- Female
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Smoking not permitted
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- No formal relationship with prescribing entity
- Private non-profit organization
- This facility administers/prescribes medication for alcohol use disorder
- Testing for Hepatitis B (HBV)
- STD testing
- Drug or alcohol urine screening
- Testing for Hepatitis C (HCV)
- Drug and alcohol oral fluid testing
- TB screening
- HIV testing
- Metabolic syndrome monitoring
- Breathalyzer or blood alcohol testing
- State-financed health insurance plan other than Medicaid
- Federal, or any government funding for substance use treatment programs
- Medicare
- SAMHSA funding/block grants
- Medicaid
- Regular outpatient treatment
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Drug Enforcement Agency (DEA)
- State mental health department
- State department of health
- The Joint Commission
- State Substance use treatment agency
- Smoking/vaping/tobacco cessation counseling
- Health education services other than HIV/AIDS or hepatitis
- Hepatitis education, counseling, or support
- Individual counseling
- Substance use disorder education
- Group counseling
- HIV or AIDS education, counseling, or support
- Naltrexone (extended-release, injectable)
- Medications for Hepatitis C treatment
- Buprenorphine with naloxone
- Acamprosate (Campral�)
- Buprenorphine (extended-release, injectable)
- Clonidine
- Disulfiram
- Naltrexone (oral)
- Non-nicotine smoking/tobacco cessation
- Nicotine replacement
- Buprenorphine without naloxone
- Medication for mental disorders
- Vaping not permitted
- Mentoring/peer support
- Housing services
- Assistance with obtaining social services
- Recovery coach
Treatment Approaches
Age Groups Accepted
Ancillary Services
Assessment/Pre-treatment
Other Services
Transitional Services
Language Services
Type of Opioid Treatment
Gender Accepted
Type of Care
Facility Smoking Policy
Opioid Medications used in Treatment
External Source of Medications Used for Alcohol Use Disorder Treatment
Facility Operation (e.g., Private, Public)
Type of Alcohol Use Disorder Treatment
Testing
Payment/Insurance/Funding Accepted
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
License/Certification/Accreditation
Education and Counseling Services
Pharmacotherapies
Facility Vaping Policy
Recovery Support Services
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm